Local de publicação venue para
- Development of an Anti-Acinetobacter baumannii Biofilm Phage Cocktail: Genomic Adaptation to the Host 2022
- Quinolin-(1H)-imines as a new chemotype against leishmaniasis: biological evaluation and mechanistic studies 2021
- Development and Characterization of Monoolein-Based Liposomes of Carvacrol, Cinnamaldehyde, Citral or Thymol with anti-Candida Activities. 2021
- High-resolution melting assay for genotyping variants of the CYP2C19 enzyme and predicting voriconazole effectiveness 2019
- Complex Polymorphisms in the Plasmodium falciparum Multidrug Resistance Protein 2 Gene and Its Contribution to Antimalarial Response 2014
- pfmdr1 Amplification Is Related to Increased Plasmodium falciparum In Vitro Sensitivity to the Bisquinoline Piperaquine 2012
- Selective Inhibition of Plasmodium falciparum ATPase 6 by Artemisinins and Identification of New Classes of Inhibitors after Expression in Yeast. 66. 2022
- Pharmacogene Sequencing of a Gabonese Population with Severe Plasmodium falciparum Malaria Reveals Multiple Novel Variants with Putative Relevance for Antimalarial Treatment. 65. 2021
- Erratum: Development and characterization of monoolein-based liposomes of carvacrol, cinnamaldehyde, citral, or thymol with Anti-Candida activities (Antimicrobial Agents and Chemotherapy (2021) 65:4 (e01628-20) DOI: 10.1128/AAC.01628-20). 65. 2021
- High-resolution melting assay for genotyping variants of the CYP2C19 enzyme and predicting voriconazole effectiveness. 63:e02399-18. 2019
- N-cinnamoylated aminoquinolines as promising anti-leishmanial agents, 2013
- Assessing the cost-benefit effect of a Plasmodium falciparum drug resistance mutation on parasite growth in vitro. 57:887-892. 2013
- Various pfcrt and pfmdr1 Genotypes of Plasmodium falciparum Cocirculate with P. malariae, P. ovale spp., and P. vivax in Northern Angola. 56:5271-5277. 2012
- In vitro antileishmanial activity of nicotinamide. 49:808-812. 2005
- Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection. 44:2424-2430. 2000